FDA Approves First AI-Powered Radiation Exposure Reduction Solution
By MedImaging International staff writers Posted on 16 Apr 2019 |
Image: The FDA has cleared FluoroShield, the first AI-powered radiation exposure reduction solution (Photo courtesy of Omega Medical Imaging).
An artificial intelligence (AI) powered region of interest (ROI) radiation exposure reduction solution for interventional X-ray imaging has received clearance from the US FDA. The solution named FluoroShield has been developed by Omega Medical Imaging (Sanford, FL, USA) in conjunction with its technology partner IKOMED Technologies (Vancouver, BC Canada). Omega Medical Imaging designs, manufactures, delivers, and supports Interventional X-Ray Imaging devices for hospitals and healthcare facilities around the globe. IKOMED Technologies is a medical device company developing novel medical solutions based on proprietary technology.
FluoroShield is available only on Omega Medical Imaging’s Flat Panel detector CS-series product lines. It combines the power of AI, an ultra-fast collimator and the world’s most advanced image processing to deliver a ROI solution that has shown to reduce radiation exposure up to ~84%, seamlessly helping interventional clinicians to reach their ALARA goals. According to the company, the FluoroShield system utilizes AI to minimize X-ray dose to patients and staff, and uses TruBlock technology to completely block radiation. It delivers maximum radiation reduction, while optimizing workflow and achieves NextLevel image quality.
“FluoroShield is a critical piece of our innovation pipeline of solutions aimed at helping our partners deliver the best in patient outcomes and efficiencies,” said Brian Fleming, President of Omega Medical Imaging.
Related Links:
Omega Medical Imaging
IKOMED Technologies
FluoroShield is available only on Omega Medical Imaging’s Flat Panel detector CS-series product lines. It combines the power of AI, an ultra-fast collimator and the world’s most advanced image processing to deliver a ROI solution that has shown to reduce radiation exposure up to ~84%, seamlessly helping interventional clinicians to reach their ALARA goals. According to the company, the FluoroShield system utilizes AI to minimize X-ray dose to patients and staff, and uses TruBlock technology to completely block radiation. It delivers maximum radiation reduction, while optimizing workflow and achieves NextLevel image quality.
“FluoroShield is a critical piece of our innovation pipeline of solutions aimed at helping our partners deliver the best in patient outcomes and efficiencies,” said Brian Fleming, President of Omega Medical Imaging.
Related Links:
Omega Medical Imaging
IKOMED Technologies
Latest Industry News News
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures